The lipid-regulating effects of atorvastatin on type 2 elder diabetes patients with hyperlipidemia

Tu Ling , Liu Xiaoqing , Li Renli , Huang Kui , Yao Hanhua , Fan Qiao

Current Medical Science ›› 2004, Vol. 24 ›› Issue (9) : 138 -139.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (9) : 138 -139. DOI: 10.1007/BF02885412
Article

The lipid-regulating effects of atorvastatin on type 2 elder diabetes patients with hyperlipidemia

Author information +
History +
PDF

Abstract

To investigate the effect of atorvastatin on lipid metabolism in type 2 elder diabetes patients with hyperlipidemia, 26 patients with type 2 elder diabetes complicated with hyperlipidemia were treated with atorvastatin (10 mg/d) for 8 weeks. The serum triglyceride (TG), high density protein cholesterol (HDL-C) and low density protein cholesterol (LDL-C) were measured before and after the treatment. Meanwhile, the non-denaturing polyacrylamide gradient gel electrophoresis was used for detection of small-sized LDL (SLDL). Our results showed that TG dropped from 4.88±0.72 mmol/L to 2.65±0.32 mmol/L; HDL-C was increased from 0.85±0.31 mmol/L to 1.28±0.29 mmol/L; LDL-C was declined from 3.71±2.98 mmol/L to 2.10±1.22 mmol/L, sLDL-A was increased from (42.49±8.1)% to (53.27±7.5)%; LDL-B was decreased from (57.91±8.1)% to (46.73±7.5%) (P<0.05). The level of blood glucose was not changed at the end of 8th week. It is concluded that atorvastatin has satisfactory lipid-regulating effects on type 2 elder diabetes patients with hyperlipidemia.

Keywords

Atorvastatin diabetes hyperlipidemia

Cite this article

Download citation ▾
Tu Ling, Liu Xiaoqing, Li Renli, Huang Kui, Yao Hanhua, Fan Qiao. The lipid-regulating effects of atorvastatin on type 2 elder diabetes patients with hyperlipidemia. Current Medical Science, 2004, 24(9): 138-139 DOI:10.1007/BF02885412

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AshidaY, TakagiA, IkedaY. Improved method for non-denaturing polyacrylamide gadient gel electrophoresis for detection of small-sized LDL produced during postprandial hypertriglyceridaemia. Scan J Clin Lab Invest, 1999, 59663-663

[2]

UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ, 1998, 317(7160): 720-720

[3]

KantersS D, AlgraA, de BraintT W, et al. . Intensive lipid-lowering strategy in patients with diabetes mediatus. Diabet Med, 1999, 16500-500

[4]

DavidsonM H, NawrockiJ, WeissS R, et al. . Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program Treatment goals. Am J Cardiol, 1997, 80347-347

AI Summary AI Mindmap
PDF

85

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/